Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients

Recruiting now

Conditions studied: Pneumonia, Next-generation Sequencing, Microbiome, Antimicrobial Resistance

In brief

Monitoring of antimicrobial resistance (AMR) based on metagenomics analyses in pneumonia patients is critical for optimizing clinical diagnosis and treatment and improving clinical prognosis. This study is designed to ask the following key questions: 1. What is the microbiome maps of patients with severe pneumonia and mild pneumonia ? 2. How many pathogen resistance genes are carrying in severe pneumonia and mild pneumonia ? 3. What is the genetic diversity of key pathogens detected in severe pneumonia and mild pneumonia during 2019-2025?

Key facts

Study ID
NCT06566898
Run by
Shanghai General Hospital, China
People needed
800
Starts
2024-08-01
Expected to finish
2026-09-30
Last updated by the study team
2026-04-23

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.